{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:08:44Z","timestamp":1789880924773,"version":"4.0.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2005,5,19]],"date-time":"2005-05-19T00:00:00Z","timestamp":1116460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,5,19]],"date-time":"2005-05-19T00:00:00Z","timestamp":1116460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2005,8,1]]},"DOI":"10.1038\/sj.leu.2403802","type":"journal-article","created":{"date-parts":[[2005,5,19]],"date-time":"2005-05-19T08:05:22Z","timestamp":1116489922000},"page":"1459-1465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma"],"prefix":"10.1038","volume":"19","author":[{"given":"A J","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Clear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L K","family":"Goff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Cuthbert-Heavens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Calaminici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T A","family":"Lister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fitzgibbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,5,19]]},"reference":[{"key":"BF2403802_CR1","doi-asserted-by":"crossref","unstructured":"The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909\u20133918.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"BF2403802_CR2","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1200\/JCO.1986.4.10.1470","volume":"4","author":"CJ Gallagher","year":"1986","unstructured":"Gallagher CJ, Gregory WM, Jones AE, Stansfeld AG, Richards MA, Dhaliwal HS et al. Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol 1986; 4: 1470\u20131480.","journal-title":"J Clin Oncol"},{"key":"BF2403802_CR3","first-page":"75","volume":"20","author":"SJ Horning","year":"1993","unstructured":"Horning SJ . Natural history of and therapy for the indolent non-Hodgkin's lymphomas. Semin Oncol 1993; 20: 75\u201388.","journal-title":"Semin Oncol"},{"key":"BF2403802_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/1097-0142(197908)44:2<645::AID-CNCR2820440234>3.0.CO;2-Y","volume":"44","author":"MH Cullen","year":"1979","unstructured":"Cullen MH, Lister TA, Brearley RI, Shand WS, Stansfeld AG . Histological transformation of non-Hodgkin's lymphoma: a prospective study. Cancer 1979; 44: 645\u2013651.","journal-title":"Cancer"},{"key":"BF2403802_CR5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1182\/blood.V59.2.258.258","volume":"59","author":"SM Hubbard","year":"1982","unstructured":"Hubbard SM, Chabner BA, DeVita Jr VT, Simon R, Berard CW, Jones RB et al. Histologic progression in non-Hodgkin's lymphoma. Blood 1982; 59: 258\u2013264.","journal-title":"Blood"},{"key":"BF2403802_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1200\/JCO.1983.1.1.11","volume":"1","author":"B Acker","year":"1983","unstructured":"Acker B, Hoppe RT, Colby TV, Cox RS, Kaplan HS, Rosenberg SA . Histologic conversion in the non-Hodgkin's lymphomas. J Clin Oncol 1983; 1: 11\u201316.","journal-title":"J Clin Oncol"},{"key":"BF2403802_CR7","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","volume":"15","author":"Y Bastion","year":"1997","unstructured":"Bastion Y, Sebban C, Berger F, Felman P, Salles G, Dumontet C et al. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol 1997; 15: 1587\u20131594.","journal-title":"J Clin Oncol"},{"key":"BF2403802_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/1097-0142(19830801)52:3<393::AID-CNCR2820520302>3.0.CO;2-M","volume":"52","author":"AJ Garvin","year":"1983","unstructured":"Garvin AJ, Simon RM, Osborne CK, Merrill J, Young RC, Berard CW . An autopsy study of histologic progression in non-Hodgkin's lymphomas 192 cases from the National Cancer Institute. Cancer 1983; 52: 393\u2013398.","journal-title":"Cancer"},{"key":"BF2403802_CR9","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1023\/A:1008349427337","volume":"9","author":"JM Foran","year":"1998","unstructured":"Foran JM, Apostolidis J, Papamichael D, Norton AJ, Matthews J, Amess JA et al. High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre. Ann Oncol 1998; 9: 865\u2013869.","journal-title":"Ann Oncol"},{"key":"BF2403802_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1046\/j.1365-2141.2001.02705.x","volume":"113","author":"CI Chen","year":"2001","unstructured":"Chen CI, Crump M, Tsang R, Stewart AK, Keating A . Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma. Br J Haematol 2001; 113: 202\u2013208.","journal-title":"Br J Haematol"},{"key":"BF2403802_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1054\/bjoc.2000.1638","volume":"84","author":"RE Hough","year":"2001","unstructured":"Hough RE, Goepel JR, Alcock HE, Hancock BW, Lorigan PC, Hammond DW . Copy number gain at 12q12\u201314 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma. Br J Cancer 2001; 84: 499\u2013503.","journal-title":"Br J Cancer"},{"key":"BF2403802_CR12","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1046\/j.1365-2141.2000.02352.x","volume":"111","author":"LK Goff","year":"2000","unstructured":"Goff LK, Neat MJ, Crawley CR, Jones L, Jones E, Lister TA et al. The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphoma. Br J Haematol 2000; 111: 618\u2013625.","journal-title":"Br J Haematol"},{"key":"BF2403802_CR13","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1182\/blood-2002-07-2119","volume":"101","author":"JA Martinez-Climent","year":"2003","unstructured":"Martinez-Climent JA, Alizadeh AA, Segraves R, Blesa D, Rubio-Moscardo F, Albertson DG et al. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 2003; 101: 3109\u20133117.","journal-title":"Blood"},{"key":"BF2403802_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/gcc.10314","volume":"39","author":"M Hoglund","year":"2004","unstructured":"Hoglund M, Sehn L, Connors JM, Gascoyne RD, Siebert R, Sall T et al. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer 2004; 39: 195\u2013204.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF2403802_CR15","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V91.12.4677","volume":"91","author":"KS Elenitoba-Johnson","year":"1998","unstructured":"Elenitoba-Johnson KS, Gascoyne RD, Lim MS, Chhanabai M, Jaffe ES, Raffeld M . Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 1998; 91: 4677\u20134685.","journal-title":"Blood"},{"key":"BF2403802_CR16","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V80.3.758.758","volume":"80","author":"T Yano","year":"1992","unstructured":"Yano T, Jaffe ES, Longo DL, Raffeld M . MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992; 80: 758\u2013767.","journal-title":"Blood"},{"key":"BF2403802_CR17","doi-asserted-by":"publisher","first-page":"8886","DOI":"10.1073\/pnas.132253599","volume":"99","author":"IS Lossos","year":"2002","unstructured":"Lossos IS, Alizadeh AA, Diehn M, Warnke R, Thorstenson Y, Oefner PJ et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci USA 2002; 99: 8886\u20138891.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403802_CR18","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1182\/blood-2002-08-2482","volume":"102","author":"T Akasaka","year":"2003","unstructured":"Akasaka T, Lossos IS, Levy R . BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 2003; 102: 1443\u20131448.","journal-title":"Blood"},{"key":"BF2403802_CR19","first-page":"651","volume":"95","author":"D Capello","year":"2000","unstructured":"Capello D, Vitolo U, Pasqualucci L, Quattrone S, Migliaretti G, Fassone L et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood 2000; 95: 651\u2013659.","journal-title":"Blood"},{"key":"BF2403802_CR20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood.V96.2.635","volume":"96","author":"IS Lossos","year":"2000","unstructured":"Lossos IS, Levy R . Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5\u2032 noncoding regulatory region of the BCL-6 gene. Blood 2000; 96: 635\u2013639.","journal-title":"Blood"},{"key":"BF2403802_CR21","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0002-9440(10)64969-3","volume":"156","author":"Z Szereday","year":"2000","unstructured":"Szereday Z, Csernus B, Nagy M, Laszlo T, Warnke RA, Matolcsy A . Somatic mutation of the 5\u2032 noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma. Am J Pathol 2000; 156: 1017\u20131024.","journal-title":"Am J Pathol"},{"key":"BF2403802_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0300-9084(01)01356-6","volume":"84","author":"DP Guimaraes","year":"2002","unstructured":"Guimaraes DP, Hainaut P . TP53: a key gene in human cancer. Biochimie 2002; 84: 83\u201393.","journal-title":"Biochimie"},{"key":"BF2403802_CR23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/S0955-0674(00)00216-7","volume":"13","author":"KM Ryan","year":"2001","unstructured":"Ryan KM, Phillips AC, Vousden KH . Regulation and function of the p53 tumor suppressor protein. Curr Opin Cell Biol 2001; 13: 332\u2013337.","journal-title":"Curr Opin Cell Biol"},{"key":"BF2403802_CR24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/humu.10081","volume":"19","author":"M Olivier","year":"2002","unstructured":"Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P . The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 2002; 19: 607\u2013614.","journal-title":"Hum Mutat"},{"key":"BF2403802_CR25","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1182\/blood.V90.10.4078","volume":"90","author":"RK Prasad","year":"1997","unstructured":"Prasad RK, Koduru PR, Raju K, Vadmal V, Menezes G, Shah S et al. Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma. Blood 1997; 90: 4078\u20134091.","journal-title":"Blood"},{"key":"BF2403802_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJM199708213370804","volume":"337","author":"A Ichikawa","year":"1997","unstructured":"Ichikawa A, Kinoshita T, Watanabe T, Kato H, Nagai H, Tsushita K et al. Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med 1997; 337: 529\u2013534.","journal-title":"N Engl J Med"},{"key":"BF2403802_CR27","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/annonc\/mdf185","volume":"13","author":"K Leroy","year":"2002","unstructured":"Leroy K, Haioun C, Lepage E, Le Metayer N, Berger F, Labouyrie E et al. p53 gene mutations are associated with poor survival in low and low\u2013intermediate risk diffuse large B-cell lymphomas. Ann Oncol 2002; 13: 1108\u20131115.","journal-title":"Ann Oncol"},{"key":"BF2403802_CR28","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","volume":"82","author":"CA Sander","year":"1993","unstructured":"Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES et al. p53 mutation is associated with progression in follicular lymphomas. Blood 1993; 82: 1994\u20132004.","journal-title":"Blood"},{"key":"BF2403802_CR29","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V82.8.2289.2289","volume":"82","author":"F Lo Coco","year":"1993","unstructured":"Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RS, Dalla-Favera R . p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993; 82: 2289\u20132295.","journal-title":"Blood"},{"key":"BF2403802_CR30","first-page":"673","volume":"39","author":"WF Symmans","year":"1995","unstructured":"Symmans WF, Katz RL, Ordonez NG, Dalton H, Romaguera JE, Cabanillas F . Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation. Acta Cytol 1995; 39: 673\u2013682.","journal-title":"Acta Cytol"},{"key":"BF2403802_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/8816","volume":"22","author":"MT Barrett","year":"1999","unstructured":"Barrett MT, Sanchez CA, Prevo LJ, Wong DJ, Galipeau PC, Paulson TG et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet 1999; 22: 106\u2013109.","journal-title":"Nat Genet"},{"key":"BF2403802_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35106009","volume":"1","author":"T Soussi","year":"2001","unstructured":"Soussi T, Beroud C . Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001; 1: 233\u2013240.","journal-title":"Nat Rev Cancer"},{"key":"BF2403802_CR33","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"ES Jaffe","year":"2001","unstructured":"Jaffe ES, Harris NL, H S, (eds)., VJW. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001."},{"key":"BF2403802_CR34","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/sj.leu.2401889","volume":"14","author":"G Buchonnet","year":"2000","unstructured":"Buchonnet G, Lenain P, Ruminy P, Lepretre S, Stamatoullas A, Parmentier F et al. Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3\u2032 BCL2 breakpoints and evidence of a new cluster. Leukemia 2000; 14: 1563\u20131569.","journal-title":"Leukemia"},{"key":"BF2403802_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/path.1711730413","volume":"173","author":"AJ Norton","year":"1994","unstructured":"Norton AJ, Jordan S, Yeomans P . Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 1994; 173: 371\u2013379.","journal-title":"J Pathol"},{"key":"BF2403802_CR36","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P . Nonparametric estimation form incomplete observations. J Am Stat Assoc 1958; 53: 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BF2403802_CR37","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/sj.onc.1200990","volume":"14","author":"S Avigad","year":"1997","unstructured":"Avigad S, Barel D, Blau O, Malka A, Zoldan M, Mor C et al. A novel germ line p53 mutation in intron 6 in diverse childhood malignancies. Oncogene 1997; 14: 1541\u20131545.","journal-title":"Oncogene"},{"key":"BF2403802_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1044-579X(03)00015-4","volume":"13","author":"IS Lossos","year":"2003","unstructured":"Lossos IS, Levy R . Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Semin Cancer Biol 2003; 13: 191\u2013202.","journal-title":"Semin Cancer Biol"},{"key":"BF2403802_CR39","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1073\/pnas.1137463100","volume":"100","author":"KS Elenitoba-Johnson","year":"2003","unstructured":"Elenitoba-Johnson KS, Jenson SD, Abbott RT, Palais RA, Bohling SD, Lin Z et al. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc Natl Acad Sci USA 2003; 100: 7259\u20137264.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF2403802_CR40","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1182\/blood.V79.10.2701.bloodjournal79102701","volume":"79","author":"A Ichikawa","year":"1992","unstructured":"Ichikawa A, Hotta T, Takagi N, Tsushita K, Kinoshita T, Nagai H et al. Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood 1992; 79: 2701\u20132707.","journal-title":"Blood"},{"key":"BF2403802_CR41","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1002\/j.1460-2075.1994.tb06656.x","volume":"13","author":"K Ory","year":"1994","unstructured":"Ory K, Legros Y, Auguin C, Soussi T . Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J 1994; 13: 3496\u20133504.","journal-title":"EMBO J"},{"key":"BF2403802_CR42","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1086\/302575","volume":"65","author":"JM Varley","year":"1999","unstructured":"Varley JM, McGown G, Thorncroft M, James LA, Margison GP, Forster G et al. Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors. Am J Hum Genet 1999; 65: 995\u20131006.","journal-title":"Am J Hum Genet"},{"key":"BF2403802_CR43","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/sj.leu.2401090","volume":"12","author":"K Gronbaek","year":"1998","unstructured":"Gronbaek K, Nedergaard T, Andersen MK, thor Straten P, Guldberg P, Moller P et al. Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb. Leukemia 1998; 12: 1266\u20131271.","journal-title":"Leukemia"},{"key":"BF2403802_CR44","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/sj.leu.2401315","volume":"13","author":"MB Moller","year":"1999","unstructured":"Moller MB, Ino Y, Gerdes AM, Skjodt K, Louis DN, Pedersen NT . Aberrations of the p53 pathway components p53, MDM2 and CDKN2A appear independent in diffuse large B cell lymphoma. Leukemia 1999; 13: 453\u2013459.","journal-title":"Leukemia"},{"key":"BF2403802_CR45","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1182\/blood.V97.11.3552","volume":"97","author":"AM Gruszka-Westwood","year":"2001","unstructured":"Gruszka-Westwood AM, Hamoudi RA, Matutes E, Tuset E, Catovsky D . p53 abnormalities in splenic lymphoma with villous lymphocytes. Blood 2001; 97: 3552\u20133558.","journal-title":"Blood"},{"key":"BF2403802_CR46","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1182\/blood.V85.11.3239.bloodjournal85113239","volume":"85","author":"R Maestro","year":"1995","unstructured":"Maestro R, Gloghini A, Doglioni C, Gasparotto D, Vukosavljevic T, De Re V et al. MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas. Blood 1995; 85: 3239\u20133246.","journal-title":"Blood"},{"key":"BF2403802_CR47","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S1471-4914(02)02309-2","volume":"8","author":"DP Lane","year":"2002","unstructured":"Lane DP, Lain S . Therapeutic exploitation of the p53 pathway. Trends Mol Med 2002; 8: S38\u2013S42.","journal-title":"Trends Mol Med"},{"key":"BF2403802_CR48","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1182\/blood.V99.10.3806","volume":"99","author":"G Ott","year":"2002","unstructured":"Ott G, Katzenberger T, Lohr A, Kindelberger S, Rudiger T, Wilhelm M et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood 2002; 99: 3806\u20133812.","journal-title":"Blood"},{"key":"BF2403802_CR49","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1101\/gad.13.20.2670","volume":"13","author":"CA Schmitt","year":"1999","unstructured":"Schmitt CA, McCurrach ME, de Stanchina E, Wallace-Brodeur RR, Lowe SW . INK4a\/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev 1999; 13: 2670\u20132677.","journal-title":"Genes Dev"},{"key":"BF2403802_CR50","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1535-6108(02)00047-8","volume":"1","author":"CA Schmitt","year":"2002","unstructured":"Schmitt CA, Fridman JS, Yang M, Baranov E, Hoffman RM, Lowe SW . Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 2002; 1: 289\u2013298.","journal-title":"Cancer Cell"},{"key":"BF2403802_CR51","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3109\/10428199609093436","volume":"21","author":"T Watanabe","year":"1996","unstructured":"Watanabe T, Ichikawa A, Saito H, Hotta T . Overexpression of the MDM2 oncogene in leukemia and lymphoma. Leuk Lymphoma 1996; 21: 391\u2013397.","journal-title":"Leuk Lymphoma"},{"key":"BF2403802_CR52","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1101\/gad.13.20.2658","volume":"13","author":"CM Eischen","year":"1999","unstructured":"Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL . Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 1999; 13: 2658\u20132669.","journal-title":"Genes Dev"},{"key":"BF2403802_CR53","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1046\/j.1365-2559.2002.01506.x","volume":"41","author":"MB Moller","year":"2002","unstructured":"Moller MB, Nielsen O, Pedersen NT . Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma. Histopathology 2002; 41: 322\u2013330.","journal-title":"Histopathology"},{"key":"BF2403802_CR54","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/358080a0","volume":"358","author":"JD Oliner","year":"1992","unstructured":"Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B . Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 358: 80\u201383.","journal-title":"Nature"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/2403802.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403802","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/2403802.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T01:28:54Z","timestamp":1648776534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/2403802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,19]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8,1]]}},"alternative-id":["BF2403802"],"URL":"https:\/\/doi.org\/10.1038\/sj.leu.2403802","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,19]]},"assertion":[{"value":"25 October 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}